CHINA PHARMA HOLDINGS, INC. (CPHI) Operating cash flow 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$148,261FY2025 · since FY2016: $2.9M → $148,261
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $148,261 | +136.5% |
| FY2024 | -$406,063 | +42.0% |
| FY2023 | -$699,686 | -70.8% |
| FY2022 | -$409,545 | -63.9% |
| FY2021 | -$249,838 | -491.2% |
| FY2020 | -$42,260 | -106.9% |
| FY2019 | $608,312 | -67.7% |
| FY2018 | $1.9M | +123.7% |
| FY2017 | $841,216 | -70.9% |
| FY2016 | $2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Net marginCPHI Gross profitCPHI Gross marginCPHI Operating incomeCPHI Operating marginCPHI Free cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Total liabilitiesCPHI Shareholders’ equityCPHI overview →